Mus vs Nepal: Estimated antiretroviral therapy coverage among children
Mus
98
in 2025
Nepal
87
in 2025
Mus rank
1st
Nepal rank
3rd
Estimated antiretroviral therapy coverage among children over time
- Mus
- Nepal
How they compare
Mus currently reports 98 against 87 in Nepal, a difference of 11.
That makes Mus's figure about 1.1 times Nepal's.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Nepal ahead.
Mus ranks 1st and Nepal ranks 3rd of 2 regions.
Across the 3 decades both report, Mus averaged higher in 2 and Nepal in 1.
Head to head by decade
| Decade | Mus | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.8 | 4 | 4.8 | Mus |
| 2010s | 41.8 | 58.5 | 16.7 | Nepal |
| 2020s | 95.67 | 84.17 | 11.5 | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Mus or Nepal?
- Mus, at 98 against 87 in Nepal as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Mus and Nepal?
- 11, with Mus ahead.
- How many years of comparable data are there for Mus and Nepal?
- 26 years are reported by both, from 2000 to 2025.
- How do Mus and Nepal rank globally for estimated antiretroviral therapy coverage among children?
- Mus ranks 1st and Nepal ranks 3rd of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.